Article Figures & Data
Figures
- Fig 1
Infectivity of MNV-1 detected by plaque assay before (white bars) and after GSE treatment (0.2 mg/ml [gray bars] or 2 mg/ml [black bars]) in different solutions (x axis). Each column represents the average of triplicates, and each error bar indicates the data range. *, lower than the detection limit.
- Fig 2
Genomic copies of human NoVs GII.4 detected by cell-binding RT-PCR before (white bars) and after GSE treatment (0.2 mg/ml [gray bars] or 2 mg/ml [black bars]) in different solutions (x axis). Each column represents the average of triplicates, and each error bar indicates the data range.
- Fig 3
OD450 values of human NoVs GII.4 P particles detected by saliva-binding ELISA before (white bars) and after GSE treatment (0.2 mg/ml [gray bars] or 2 mg/ml [black bars]) in different solutions (x axis). Each column represents the average of triplicates, and each error bar indicates the data range.
- Fig 4
Electron micrographs of human NoVs GII.4 VLPs before (A) and after GSE treatment (0.2 mg/ml [B] or 2 mg/ml [C]).
- Fig 5
Infectivity of MNV-1 detected by plaque assay before (white bars) and after GSE treatment (0.2 mg/ml [gray bars] and 2 mg/ml [black bars]) in different practical scenarios (x axis). Each column represents the average of triplicates, and each error bar indicates the data range.
